Guide — Oxygen Therapy
High-Flow Nasal Cannula (HFNC) Therapy
HFNC delivers heated, humidified oxygen through wide-bore nasal prongs at high flow, with an independently set FiO₂. It earns its place by meeting the patient’s inspiratory demand, washing out dead space, and adding a modest, flow-dependent PEEP — a comfortable middle ground between a simple cannula and the ventilator.
9 min read · Oxygen Therapy
Written by Apex Respiratory Editorial Team
Educational use only. This material supports respiratory therapy education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional protocols, or physician orders. Always follow facility policies and current provider orders, and verify calculations independently before clinical use.
Overview
High-flow nasal cannula (HFNC) delivers heated, humidified oxygen through wide-bore nasal prongs at high flows — typically up to 50–60 L/min in adults — with an FiO₂ set independently from 0.21 to 1.0 by an air-oxygen blender. That combination of a high flow and a separately controlled oxygen fraction is what separates it from a standard low-flow cannula, where flow and FiO₂ are coupled and unstable. Clinically it sits between conventional oxygen and noninvasive ventilation: more reliable oxygenation and more comfort than a simple cannula, but far less ventilatory support than NIV.
The practical appeal is that patients tolerate it for days. Because the gas is warmed and fully humidified, HFNC does not dry out the airway the way high-flow dry oxygen does, so it is comfortable enough to keep a hypoxemic patient supported — and stable enough to read the trajectory and decide whether they are turning the corner or heading for the tube.
Key Concepts
HFNC helps through four mechanisms that work together:
- It meets the patient’s inspiratory demand.A dyspneic patient pulls a high inspiratory flow. Low-flow systems cannot keep up, so the patient entrains room air and the delivered FiO₂ is diluted and unpredictable. HFNC’s high flow meets or exceeds that demand, so the set FiO₂ is actually delivered — a high, stable oxygen fraction breath after breath.
- It washes out anatomic dead space. The high flow continuously flushes the nasopharyngeal CO₂ reservoir, so each breath starts from a cleaner compartment. That improves CO₂ clearance and the efficiency of every breath.
- It generates a modest positive airway pressure.The high flow produces a low level of positive pressure — a few cmH₂O, flow-dependent and greatest with the mouth closed — giving a modest PEEP and recruitment effect. It is a benefit, not a set, reliable PEEP.
- It is heated and humidified. Warming and fully humidifying the gas preserves mucociliary function and comfort, which is exactly why patients tolerate HFNC for days when high-flow dry oxygen would be intolerable.
Keep the headline straight: HFNC is primarily an oxygenation tool. It improves CO₂ clearance through dead-space washout, but it provides far less ventilatory support than NIV. When the problem is ventilation rather than oxygenation, that distinction decides the device.
Indications
The core indication is acute hypoxemic respiratory failure. The FLORALI trial supported HFNC against conventional oxygen and NIV in selected hypoxemic patients, and it is now a first-line strategy for that population. Beyond that, HFNC is used for:
- Post-extubation support— to help prevent reintubation in lower-risk patients after they come off the ventilator.
- Pre-oxygenation and apneic oxygenation— to build and hold a reservoir of oxygen during intubation, extending safe apnea time.
- Comfort or palliation— a tolerable way to relieve dyspnea and deliver oxygen without a tight mask.
What HFNC is not is a ventilator. Because it offers little ventilatory support, a primarily hypercapnic patient who needs pressure support to move air usually needs NIV instead.
The ROX index
The ROX index is the bedside number for tracking whether HFNC is working in hypoxemic failure. It combines oxygenation and respiratory drive into a single ratio:
ROX = (SpO₂ / FiO₂) / respiratory rate
A ROX of 4.88 or higher, measured at 2, 6, and 12 hours, predicts HFNC success. A persistently low ROX — for example below about 3.85 — flags a high risk of failure and the need to escalate to NIV or intubation. Read the trajectory, not just one value: a rising ROX is reassuring, while a low and falling ROX means the patient is failing. Do not delay escalation when the ROX is low and dropping.
Setup and weaning
Start the flow around 30–60 L/min and titrate the FiO₂ to the SpO₂ target. Always run heated humidification — it is not optional, and skipping it is what makes high flow intolerable. Then wean in a deliberate order: bring the FiO₂ down first, toward roughly 0.40–0.50, before you touch the flow. Once the FiO₂ is comfortably low, reduce the flow, and only then transition to conventional oxygen.
Throughout, watch for failure: a rising respiratory rate, a falling SpO₂ or ROX, and increasing work of breathing or distress. Those are the signs to escalate — promptly, not after another hour of watching a comfortable-looking patient quietly tire out.
What the RT does with it
At the bedside the respiratory therapist’s job is to deliver a true, stable, high FiO₂ with comfort, then read the response. Set the flow and FiO₂, confirm heated humidification is running, fit the prongs, and check that the patient is actually getting the oxygen fraction you set rather than entraining around a loose interface.
The judgment piece is tracking the ROX index and the trajectory. A reassuring trend supports staying the course and beginning to wean; a low, falling ROX with a climbing respiratory rate is the cue to escalate. The single most important rule is to not let HFNC delay a needed intubation in a deteriorating patient. And keep the device matched to the problem: HFNC supports oxygenation more than ventilation, so a primarily hypercapnic patient who needs ventilatory support usually belongs on NIV, not high flow.
Common Pitfalls
- Using HFNC as a substitute for NIV.In a primarily hypercapnic or ventilatory-failure patient, HFNC’s limited ventilatory support is not enough — that patient needs the pressure support of NIV.
- “HFNC complacency.” A comfortable-looking patient on high flow can lull the team into delaying intubation while they quietly deteriorate. Watch the ROX and the work of breathing, and escalate on the trend.
- Running it without heated humidification.Without warming and humidifying the gas, high flow dries and injures the airway and patients will not tolerate it — the humidification is core to how the therapy works.
- Forgetting that mouth-open breathing dissipates the PEEP. The modest, flow-dependent positive pressure is greatest with the mouth closed; an open mouth lets it leak away, so do not count on it as a reliable PEEP.
Board Exam Pearls
- Four mechanisms. HFNC equals a high, stable FiO₂ + dead-space washout + a modest flow-dependent PEEP + heated humidification.
- ROX index. ROX = (SpO₂/FiO₂)/RR, with 4.88 or higher predicting HFNC success and a low, falling value signaling failure.
- Oxygenation, not ventilation.HFNC is an oxygenation tool with less ventilatory support than NIV — hypercapnic ventilatory failure usually means NIV.
- FLORALI. The FLORALI trial supported HFNC in acute hypoxemic respiratory failure versus conventional oxygen and NIV in selected patients.
FAQ
How does HFNC raise FiO₂ more reliably than a standard nasal cannula?
A sick, dyspneic patient pulls a very high inspiratory flow — often well above what a standard low-flow cannula supplies. When the device cannot keep up, the patient entrains room air around the prongs and dilutes the delivered oxygen, so the actual FiO₂ drops well below the flowmeter setting and varies breath to breath. HFNC delivers flows up to 50-60 L/min that meet or exceed the patient's inspiratory demand, so the set FiO₂ from the air-oxygen blender (0.21 to 1.0) is what actually reaches the airway. The result is a high, stable, predictable FiO₂ rather than an unpredictable diluted one.
Does HFNC provide PEEP?
It provides a low, flow-dependent positive airway pressure — on the order of a few cmH₂O — not a set, reliable PEEP like a ventilator or a sealed NIV mask. The pressure rises with higher flow and is greatest when the mouth is closed; opening the mouth dissipates much of it. Treat it as a modest recruitment and splinting benefit, not as guaranteed PEEP. If a patient truly needs a set positive end-expiratory pressure, HFNC is the wrong tool.
What is the ROX index?
ROX = (SpO₂ / FiO₂) / respiratory rate. It is a simple bedside number used to track HFNC success in acute hypoxemic respiratory failure. A ROX of 4.88 or higher measured at 2, 6, and 12 hours predicts that HFNC will succeed, while a persistently low value (for example below about 3.85) flags a high risk of failure. A rising ROX over time is reassuring; a low and falling ROX is a signal to escalate to NIV or intubation rather than wait.
When should HFNC be used instead of NIV, and vice versa?
HFNC is primarily an oxygenation tool, so it fits acute hypoxemic respiratory failure, post-extubation support in lower-risk patients, pre-oxygenation and apneic oxygenation, and comfort or palliation. NIV provides far more ventilatory support and is the better choice when the problem is ventilation — a primarily hypercapnic patient in ventilatory failure usually needs the pressure support of NIV, not HFNC. Choosing HFNC for a hypercapnic patient who needs ventilation, or letting comfortable-looking HFNC delay a needed intubation, are the two most common mistakes.
Go deeper
See where high-flow sits between a cannula and the ventilator.
Compare HFNC, NIV, and conventional O₂ →Related Resources
Sources
- Kacmarek RM, Stoller JK, Heuer AJ. Egan's Fundamentals of Respiratory Care. 12th ed. Elsevier; 2021. Oxygen therapy and high-flow nasal cannula.
- Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-2196.
- Rochwerg B, Granton D, Wang DX, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020;46(12):2226-2237.